Fatty acid modified human epidermal growth factor
Abstract:
The disclosure provides for new epidermal growth factor (EGF)-based reagents that have been modified by fatty acid conjugation. Method of using such agents to treatment Short Bowel Syndrome (SBS) are also described.
Information query
Patent Agency Ranking
0/0